Gujarat State Fertilizers & Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Star Cement Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 We are enclosing herewith the Certificate dated 03.01.2022 issued by Maheshwari Datamatics Pvt. Ltd., Registrar and Transfer Agent (RTA) of the company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This is for your information and record. .
Future Consumer Limited has informed the Exchange regarding reason for encumbrance vide letter dated January 05, 2022 under SEBI (SAST) Regulations, 2011.
Shyam Century Ferrous Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 We are enclosing herewith the Certificate dated 03.01.2022 issued by Maheshwari Datamatics Pvt. Ltd., Registrar and Transfer Agent (RTA) of the company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This is for your information and record.
Atul Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
DRC Systems India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BIRLASOFT LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Bohra Industries Limited has informed the Exchange regarding Board meeting held on January 05, 2022.
Bharat Rasayan Limited has informed the Exchange regarding Intimation u/r 30 of SEBI (LODR) for acquisition of Land. situated at Plot No.D-3/21/2/1 at Dhahej-3, Industrial Estate from GIDC Authority for future expansion and new projects.
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 06, 2022, titled Alembic Pharmaceuticals receives USFDA Final Approval for Entacapone Tablets USP, 200 mg.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
